EODData

MEMBERSHIP REGISTER LOG IN

FRA, NG9: NeoGenomics Inc

04 Sep 2026
LAST:

14.83

CHANGE:
 0.02		OPEN:
14.83		HIGH:
14.83		ASK:
0.00		VOLUME:
0
CHG(%):
0.13		PREV:
14.85		LOW:
14.83		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 2614.8314.8314.8314.830
03 Sep 2614.8514.8514.8514.850
02 Sep 2614.8814.8814.8814.880
31 Aug 2615.4815.4815.4815.4875
28 Aug 2615.8315.8315.7315.730
27 Aug 2615.1915.1915.1915.190
26 Aug 2614.2214.2214.2214.220
25 Aug 2613.8713.8713.8713.870
24 Aug 2614.3514.3514.3514.350
21 Aug 2614.0114.0114.0114.010

PROFILE

Name:NeoGenomics Inc
About:NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Sector:Healthcare
Address:9490 NeoGenomics Way, Fort Myers, FL, United States, 33912
Website:https://www.neogenomics.com
ISIN:US64049M2098

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.67 
Forward P/E:-87.53 
PEG Ratio:0.16 
Price to Sales:2.35 
Price to Book:2.64 
Profit Margin:-0.07 
Operating Margin:-0.05 
Return on Assets:-0.02 
Return on Equity:-0.06 
Revenue:654.71M 
EBITDA:20.78M 
Shares:129.18M 
Market Cap:1.915B 

TECHNICAL INDICATORS

MA5:15.152.2%
MA10:14.740.6%
MA20:14.293.8%
MA50:12.9714.3%
MA100:10.3942.7%
MA200:9.7951.5%
STO9:48.98
STO14:56.24
RSI14:57.37
WPR14:-41.19
MTM14:1.25
ROC14:0.09 
ATR:0.39 
Week High:15.836.7%
Week Low:14.830.0%
Month High:15.836.7%
Month Low:13.3251.5%
Year High:15.836.7%
Year Low:6.20139.1%
Volatility:49.94